Phibro Animal Health (PAHC) Capital Expenditures Growth (3y) (2016 - 2026)
Powered by 
Analysis
Phibro Animal Health (PAHC) Capital Expenditures Growth (3y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.52 Bn | 40.33 Bn | 779.09 Mn | -3.55% |
| 2 | Zoetis | 30.69 Bn | 29.02 Bn | 1.05 Bn | -11.01% |
| 3 | Elanco Animal Health | 11.89 Bn | 11.36 Bn | 798.00 Mn | -7.72% |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn | 20.10% |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 75.05 Mn | 67.96 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.10% |
| Mar 31, 2026 | 24.65% |
| Dec 31, 2025 | 4.16% |
| Sep 30, 2025 | -15.86% |
| Jun 30, 2025 | 3.39% |
| Mar 31, 2025 | -8.21% |
| Dec 31, 2024 | 0.57% |
| Sep 30, 2024 | 8.76% |
| Jun 30, 2024 | 22.60% |
| Mar 31, 2024 | 9.13% |
| Dec 31, 2023 | 14.41% |
| Sep 30, 2023 | 0.25% |
| Jun 30, 2023 | 2.63% |
| Mar 31, 2023 | 0.23% |
| Dec 31, 2022 | 5.17% |
| Sep 30, 2022 | 44.54% |
| Jun 30, 2022 | 5.53% |
| Mar 31, 2022 | 9.36% |
| Dec 31, 2021 | 8.22% |
| Sep 30, 2021 | 7.19% |